-
Topological Stress, rDNA Lesions, and PML-Nucleolar Bodies
2026-09-27
Urbancokova, Hornofova and colleagues identify persistent ribosomal DNA damage, particularly damage associated with topological stress and RNA polymerase I inhibition, as a trigger for PML-nucleolar associations. Their experiments connect nucleolar cap formation and homologous-recombination-associated responses with the sequestration of damaged rDNA, offering a framework for studying nucleolar genome stability and its relationship to senescence.
-
HPF in Phototherapy: Interpreting ROS Signals
2026-09-26
Learn how HPF (hydroxyphenyl fluorescein) can help investigate highly reactive oxygen species in phototherapy research—and why its fluorescence should be interpreted as a selective signal, not a complete measure of oxidative stress. This guide connects probe chemistry to experimental design for NIR-triggered multimodal therapy.
-
Histone Hyperacetylation Disrupts Spermatogenesis
2026-09-26
In a mouse model, Panobinostat-induced histone hyperacetylation was associated with disruption of the spermatogonial stem cell niche, impaired spermiogenesis, and poorer sperm parameters. The study connects testicular histology, cell-marker analysis, and RNA sequencing to describe a potential link between altered chromatin regulation and male reproductive dysfunction.
-
Phosphatase Inhibitor Cocktail 3: Use & Limits
2026-09-25
Phosphatase Inhibitor Cocktail 3 is a 100X serine/threonine phosphatase inhibitor for preserving protein phosphorylation during sample preparation. This guide explains its fit for phosphoprotein analysis, how to dilute and store it, and why it should not be interpreted as a direct inhibitor of ferroptosis or mitochondrial pore opening.
-
Cefodizime: In Vitro Workflows and Applications
2026-09-25
Build focused in vitro assays around Cefodizime’s PBP-directed activity, susceptibility profile, and reported immunomodulatory properties. This research guide translates organism-specific MIC benchmarks into practical workflows, with controls and troubleshooting to keep results interpretable—not clinical treatment advice.
-
AI-10-49 Workflows for inv(16) AML Research
2026-09-24
Use AI-10-49 to connect disruption of the CBFβ-SMMHC–RUNX1 interaction with transcriptional, chromatin, and leukemia-survival readouts in inv(16) AML models. This practical workflow pairs target engagement with N-MYC/eIF4G1 analysis and includes controls for solubility, timing, and interpretation.
-
FGFR3 Inhibition in SLC26A2 Chondrodysplasia
2026-09-24
A mouse study combines genetic disruption of Fgfr3 with pharmacological inhibition to test whether excess FGFR3 signaling contributes to SLC26A2-related skeletal dysplasia. Its results support FGFR3 as a modifiable contributor to the phenotype, while the partial rescue and preclinical models leave important questions for translation to human disease.
-
ATG4B Nuclear Translocation and AML DNA Repair
2026-09-23
The 2025 Advanced Science study identifies an energy-sensitive ATG4B–PRMT1–MRE11 pathway that connects metabolic stress with defective DNA repair and leukemia progression. Its models suggest that inhibiting ATG4B can restore DNA damage responses, reduce mutation burden, and improve survival in experimental acute myeloid leukemia, although clinical translation remains unestablished.
-
NVP-BGJ398 Phosphate: Signal-to-Phenotype
2026-09-23
NVP-BGJ398 phosphate is a potent FGFR1–3 inhibitor for connecting molecular target engagement with cancer and skeletal-disease phenotypes. This article presents a signal-to-phenotype framework that extends beyond routine workflow guidance and clarifies how to interpret FGFR3 evidence.
-
Rucaparib (AG-014699) DNA Repair Workflows
2026-09-22
Rucaparib (AG-014699) supports reproducible studies of PARP1 inhibition, persistent DNA breaks, and radiation response. This workflow connects prostate cancer radiosensitization with emerging SmD2–BRCA1/FANC splicing biology in hepatocellular carcinoma.
-
Lysis Buffer for Mouse Genotyping: From DNA to Data
2026-09-21
Explore how a lysis buffer functions as a rapid genotyping kit component for consistent genomic DNA release from mouse tissues. This article connects pre-analytical DNA quality with assay selection and interprets a colorectal cancer transcriptomics study without overstating what the product can support.
-
NVP-BGJ398 Phosphate: FGFR Research Workflows
2026-09-21
NVP-BGJ398 phosphate enables genotype-aware inhibition of FGFR1–3 signaling in cancer and cartilage research. This workflow-focused guide connects target engagement, phenotypic assays, and troubleshooting for FGFR-altered tumors and SLC26A2-related skeletal disease models.
-
Dabigatran: Designing Causal Coagulation Assays
2026-09-20
Dabigatran is examined here as a causal research probe rather than only a clinical anticoagulant. This guide integrates thrombin biology, assay interpretation, and insights from catalpol cardiovascular research to help investigators design more discriminating coagulation studies.
-
Reserpine (N1867): Practical Research Guide
2026-09-19
Reserpine (N1867) provides a characterized research reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide addresses identity confirmation, solvent selection, preparation, storage, and QC; the product is for research use only and should not be used for diagnostic or medical applications.
-
Gramine Workflow for TNBC Ferroptosis Research
2026-09-19
Use Gramine as a mechanism-focused probe to connect TNBC growth inhibition with ferroptosis, MTDH regulation, and CUL3 target engagement. This practical workflow covers formulation, dose-response design, orthogonal validation, rescue experiments, and troubleshooting for reproducible cancer biology research.